Chemomab Therapeutics Ltd. Key Management Personnel Compensation Shortterm Employee Benefits
Chemomab Therapeutics Ltd. (CMMB) reported Key Management Personnel Compensation Shortterm Employee Benefits of $1.23 million for the 12-month period ending 2018-12-31, per its 20-F filed 2019-04-24.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits · last filed 2019-04-24
| Period end | Key Management Personnel Compensation Shortterm Employee Benefits 12 month |
|---|---|
| 2018-12-31 | $1.23M 20-F · filed 2019-04-24 |
| 2017-12-31 | $970.00K 20-F · filed 2019-04-24 |